Socially optimal pandemic drug dosing
- PMID: 34139194
- PMCID: PMC8203182
- DOI: 10.1016/S2214-109X(21)00251-5
Socially optimal pandemic drug dosing
Conflict of interest statement
GWS and PDR are co-inventors of a filed patent covering the use of low-dose tocilizumab in viral infections. WFP is supported by a grant from the US National Institutes of Health (K08 HL150291). WFG declares no competing interests. The views expressed are those of the authors alone and do not necessarily represent those of the Department of Veterans Affairs or the US Government.
References
-
- Emanuel EJ, Persad G, Upshur R. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;382:2049–2055. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical